Document:

<PAGE>   1

                                                                     EXHIBIT 4.2

                       CERTIFICATE OF CORPORATE RESOLUTION
                            OF THE BOARD OF DIRECTORS
                           OF W HOLDING COMPANY, INC.

                                 DESIGNATING
           7.60% NONCUMULATIVE MONTHLY INCOME PREFERRED STOCK, 2001
                               SERIES C, PAR VALUE
                                 $1.00 PER SHARE
                     (LIQUIDATION PREFERENCE $25 PER SHARE)

        WHEREAS, the Certificate of Incorporation (the "Charter") of W Holding
Company, Inc. (the "Company") authorizes the issuance of 20,000,000 shares of
the Company's preferred stock, par value $1.00 per share ("Preferred Stock"), in
one or more series, and authorizes the Board of Directors to fix by resolution
or resolutions the designation of each series of Preferred Stock and the powers,
preferences and relative, participation, optional or other special rights, and
qualifications, limitations or restrictions thereof; and

        WHEREAS, the Board of Directors of the Company has determined that the
preferences and relative, participating, optional and other special rights, and
qualifications, limitations or restrictions of the 7.60% Noncumulative Monthly
Income Preferred Stock, 2001 Series C, liquidation preference $25 per share,
stated and expressed herein are, under the circumstances prevailing at this
time, fair and equitable to all existing stockholders;

        NOW, THEREFORE, BE IT RESOLVED, that the Board of Directors, in
accordance with the provisions of the Charter, hereby approves the issuance of
7.60% Noncumulative Monthly Income Preferred Stock, 2001 Series C, liquidation
preference $25 per share, par value $1.00 per share, of the Company and fixes
the designation of such 7.60% Noncumulative Monthly Income Preferred Stock,
2001 Series C, liquidation preference $25 per share, and the powers,
preferences, rights, and qualifications, limitations and restrictions thereof,
in addition to those set forth in the Charter, as follows:

       1.    DESIGNATION; RANKING.

       (a)   The designation of such series of Preferred Stock shall be "7.60%
Noncumulative Monthly Income Preferred Stock, 2001 Series C" (hereinafter
referred to as "Series C Preferred Stock"), and the number of shares
constituting such series shall be 2,208,000, which number may be increased (but
not above the total number of shares of authorized Preferred Stock) or decreased
(but not below the number of shares of Series C Preferred Stock then
outstanding) from time to time by the Board of Directors.
<PAGE>   2

       (b)   The Series C Preferred Stock will, with respect to dividend rights
and rights on liquidation, rank (i) senior to all classes of common stock of the
Company, par value $1.00 per share (the "Common Stock") and to all other equity
securities issued by the Company the terms of which specifically provide that
such equity securities will rank junior to the Series C Preferred Stock (or to
all series of the Preferred Stock in general) as to dividends and the
distribution of assets upon liquidation (the Common Stock, together with such
other equity securities, being hereinafter referred to as "Junior Stock"); (ii)
on a parity with the Company's 7.125% Non-Cumulative, Convertible Preferred
Stock, Series A and the Company's 7.25% Noncumulative Monthly Income Preferred
Stock, 1999 Series B and all other equity securities issued by the Company the
terms of which specifically provide that such equity securities will rank on a
parity to the Series C Preferred Stock as to dividends or the distribution of
assets upon liquidation ("Parity Stock"); and (iii) junior to all equity
securities issued by the Company the terms of which specifically provide that
such equity securities will rank senior to the Series C Preferred Stock as to
dividends or the distribution of assets upon liquidation. For this purpose, the
term "equity securities" does not include debt securities convertible into or
exchangeable for equity securities.

       (c)   The Company may not issue capital stock ranking, as to dividend
rights or rights on liquidation, senior to the Series C Preferred Stock except
with the consent of the holders of at least two-thirds of the aggregate
liquidation preference of the Series C Preferred Stock and any series of Parity
Stock at the time outstanding.

       2.    DIVIDEND RIGHTS.

       (a)   The holders of Series C Preferred Stock shall be entitled to
receive when, as and if declared by the Board of Directors of the Company, out
of assets of the Company legally available therefor, cash dividends, accruing
from the date of original issuance (the "Issue Date") at the annual rate per
share of 7.60% of the liquidation preference of $25 per share (equivalent to
$1.90 per share per annum) (the "Dividends"), payable, when, as and if
declared by the Board of Directors, monthly in arrears on the 15th day of each
month (each monthly period ending on any such date being hereinafter referred to
as a "dividend period"), at such annual rate. Dividends in each dividend period
shall accrue from the first day of such period, whether or not declared or paid
for the prior dividend period (except that the first Dividends payable after the
Issue Date shall accrue from the Issue Date). Each declared Dividend shall be
payable to holders of record as they appear at the close of business on the
stock register of the Company on such record dates, not exceeding 45 days
preceding the payment dates thereof, as shall be fixed by the Board of Directors
of the Company. Dividends (1) for any period other than a full dividend period,
will be computed on the basis of a 360-day year consisting of twelve 30-day
months and (2) for each full dividend period, will be computed by dividing the
annual dividend rate by 12.
<PAGE>   3

       (b)   Dividends shall be noncumulative. The Company is not obligated or
required to declare or pay Dividends, even if it has funds available for the
payment of such dividends. If the Board of Directors of the Company or an
authorized committee thereof does not declare a Dividend payable on a dividend
payment date, then the holders of such Series C Preferred Stock shall have no
right to receive a Dividend in respect of the dividend period ending on such
dividend payment date, and the Company will have no obligation to pay a Dividend
accrued for such dividend period or to pay any interest thereon, whether or not
dividends on such Series C Preferred Stock or the Common Stock are declared for
any future dividend period.

       (c)   If all Dividends due and payable for each of the twelve previous
monthly dividend periods (or such fewer dividend periods as there actually are)
shall not have been declared and paid, or declared and a sum sufficient for the
payment thereof shall not have been set apart for such payments, or the Company
has defaulted on the payment of the redemption price of any Series C Preferred
Stock called for redemption, no dividends shall be declared or paid or set aside
for payment and no other distribution shall be declared or made or set aside for
payment upon the Junior Stock, nor shall any Junior Stock be redeemed, purchased
or otherwise acquired for any consideration (or any monies to be paid to or made
available for a sinking fund for the redemption of any such stock) by the
Company (except by conversion into or exchange for other Junior Stock).

       (d)   When Dividends and dividends upon any Parity Stock are not paid in
full (or a sum sufficient for such full payment is not set apart), all dividends
declared upon the Series C Preferred Stock and any Parity Stock will be declared
pro rata so that the amount of Dividends and dividends upon the other series of
capital stock will in all cases bear to each other the same ratio that full
Dividends, for the then-current dividend period (which will not include any
accumulation in respect of unpaid Dividends for prior dividend periods), and
full dividends, including required or permitted accumulations, if any, on the
Parity Stock, bear to each other.

       (e)   Subject to any applicable laws and regulations, each Dividend
payment will be made by U.S. dollar check drawn on a bank in New York, New York
or San Juan, Puerto Rico and mailed to the record holder thereof at such
holder's address as it appears on the register for such Series C Preferred
Stock.

       3.    LIQUIDATION PREFERENCES.

       (a)   In the event of any liquidation of the Company, whether voluntary
or involuntary, the holders of Series C Preferred Stock shall be entitled to
receive out of the assets of the Company available for distribution to
shareholders an amount equal to $25 per share, plus accrued and unpaid
dividends, if any, for the then-current monthly dividend period to the date of
payment, and no more (the

<PAGE>   4

"Liquidation Preference"), before any distribution shall be made to the holders
of Junior Stock. After payment of the full amount of such liquidating
distributions, the holders of Series C Preferred Stock will not be entitled to
any further participation in any distribution of the remaining assets of the
Company.

       (b)   If the assets of the Company available for distribution to
shareholders upon any liquidation of the Company, whether voluntary or
involuntary, shall be insufficient to pay in full the amounts payable with
respect to the Series C Preferred Stock and any Parity Stock, the holders of
Series C Preferred Stock and Parity Stock shall share ratably in any
distribution of assets of the Company in proportion to the full liquidating
distributions to which they would otherwise be respectively entitled.

       (c)   The merger or consolidation of the Company with or into any other
entity, the merger or consolidation of any other entity with or into the
Company, or the sale, lease or conveyance of all or substantially all of the
property or business of the Company, shall not be deemed to constitute a
liquidation of the Company within the meaning of this Section 3.

       4.    NO MATURITY DATE OR MANDATORY REDEMPTION.

       The Series C Preferred Stock will not mature on a specified date and is
not subject to any mandatory redemption, sinking fund or similar obligation.
Holders will have no right to require the Company to repurchase or redeem any
shares of Series C Preferred Stock.

       5.    REDEMPTION.

       (a)   Holders of the Series C Preferred Stock will have no right to
require the Company to redeem or repurchase the Series C Preferred Stock and
such shares are not subject to any sinking fund or similar obligation.

       (b)   The Series C Preferred Stock will not be redeemable, in whole or in
part, before March 30, 2006. After March 30, 2006, the Series C Preferred Stock
will be redeemable at the option of the Company, at any time or from time to
time, upon not less than 30 nor more than 60 days' notice by mail, at the
following redemption prices, plus accrued and unpaid dividends, if any, for the
then-current dividend period to the date fixed for redemption:

<TABLE>
<CAPTION>
        YEAR                                                       REDEMPTION
        ----                                                          PRICE
                                                                   ----------

<S>                                                                  <C>
        2006....................................................     $25.50
        2007....................................................     $25.25
        2008 and thereafter.....................................     $25.00
</TABLE>

<PAGE>   5

       (c)   If less than all of the outstanding shares of the Series C
Preferred Stock are to be redeemed at the option of the Company, the total
number of shares to be redeemed in such redemption shall be determined by the
Board of Directors, and the shares to be redeemed shall be allocated pro rata or
by lot as may be determined by the Board of Directors or by such other method as
the Board of Directors may approve and deem fair and appropriate, including any
method to conform to any rule or regulation of any national or regional stock
exchange or automated quotation system upon which the shares of the Series C
Preferred Stock may at the time be listed or eligible for quotation; provided
that, the shares of a holder must be redeemable in full unless the Company
obtains a ruling from the Puerto Rico Treasury Department or an opinion from
reputable counsel knowledgeable in Puerto Rico income tax matters to the effect
that the redemption in part of the holder's shares is not equivalent to a
dividend under Puerto Rico law.

       (d)   Notice of any redemption shall be given by first class mail,
postage prepaid, mailed not less than 30 nor more than 60 days prior to the date
fixed for redemption to each holder of record of the Series C Preferred Stock to
be redeemed, at their respective addresses appearing on the stock books of the
Company. Notice so mailed shall be conclusively presumed to have been duly given
whether or not actually received, and failure to duly give such notice by mail,
or any defect in such notice, to the holders of any shares designated for
redemption shall not affect the validity of the proceedings for the redemption
of any other shares of Series C Preferred Stock. Such notice shall state: (i)
the Redemption Date; (ii) the redemption price; (iii) the number of shares of
Series C Preferred Stock to be redeemed and, if less than all the shares held by
such holder are to be redeemed, the number of such shares to be so redeemed from
such holder; (iv) the place where certificates for such shares are to be
surrendered for payment of the redemption price; and (v) that after such
Redemption Date the shares to be redeemed shall not accrue dividends. If such
notice is mailed as aforesaid, and if on or before the Redemption Date funds
sufficient to redeem the shares called for redemption are set aside by the
Company in trust for the account of the holders of the shares to be redeemed,
notwithstanding the fact that any certificate for shares called for redemption
shall not have been surrendered for cancellation, on and after the Redemption
Date the shares represented thereby so called for redemption shall be deemed to
be no longer outstanding, dividends thereon shall cease to accrue, and all
rights of the holders of such shares as stockholders of the Company shall cease,
except the right to receive the redemption price, without interest, upon
surrender of the certificate representing such shares. Upon surrender in
accordance with the aforesaid notice of the certificate for any shares so
redeemed (duly endorsed or accompanied by appropriate instruments of transfer,
if so required by the Company in such notice), the holders of record of such
shares shall be entitled to receive the redemption price, without interest. In
case fewer than all the shares represented by any such certificate are redeemed,
a new certificate shall be issued representing the unredeemed shares without
cost to the holder thereof.
<PAGE>   6

       (e)   At its option, the Company may, on or prior to the Redemption Date,
irrevocably deposit the aggregate amount payable upon redemption of the shares
of the Series C Preferred Stock to be redeemed with a bank or trust bank
designated by the Company having its principal office in New York, New York, San
Juan, Puerto Rico, or any other city in which the Company shall at that time
maintain a transfer agent with respect to its capital stock, and having a
combined capital surplus (as shown by its latest published statement) of at
least $50,000,000 (hereinafter referred to as the "Depository"), to be held in
trust by the Depository for payment to the holders of the Series C Preferred
Stock to be redeemed. If such deposit is made and the funds so deposited are
made immediately available to the holders of the Series C Preferred Stock to be
redeemed, the Company shall thereupon be released and discharged (subject to the
provisions described in the next paragraph) from any obligation to make payment
of the amount payable upon redemption of the Series C Preferred Stock to be
redeemed, and the holders of such shares shall look only to the Depository for
such payment.

       (f)   Any funds remaining unclaimed at the end of two years from and
after the Redemption Date in respect of which such funds were deposited shall be
returned to the Company forthwith and thereafter the holders of the Series C
Preferred Stock called for redemption with respect to which such funds were
deposited shall look only to the Company for the payment of the redemption price
thereof. Any interest accrued on any funds deposited with the Depository shall
belong to the Company and shall be paid to it from time to time on demand. Any
of the Series C Preferred Stock which shall at any time have been redeemed
shall, after such redemption, have the status of authorized but unissued
preferred shares, without designation as to series, until such shares are once
more designated as part of a particular series by the Board of Directors.

       (g)   To the extent required to have the Series C Preferred Stock treated
as Tier 1 capital for bank regulatory purposes or otherwise required by
applicable regulations of the Federal Reserve Board, the shares of Series C
Preferred Stock may not be redeemed by the Company without the prior consent of
the Board of Governors of the Federal Reserve System.

       6.    VOTING RIGHTS.

       (a)   Except as expressly required by applicable law, or except as
indicated below, the holders of the Series C Preferred Stock will not be
entitled to receive notice of, or attend or vote at, any meeting of the
stockholders of the Company.

       (b)   If at the time of any annual meeting of the Company's stockholders
for the election of directors, the Company has failed to pay or declare and set
aside for payment a monthly Dividend for each of the 18 preceding monthly
dividend periods, the number of directors then constituting the Board of
Directors of the Company shall be increased by one (if not already increased by
one due to a default in
<PAGE>   7

preference dividends), and at such annual meeting the holders of the Series C
Preferred Stock, along with the holders of any other series of Preferred Stock
which may have voting rights due to the Company's failure to pay dividends, will
be entitled to elect such additional director to serve on the Company's Board of
Directors. Such director elected by the holders of the Series C Preferred Stock
and any other Preferred Stock shall continue to serve as director until the
earlier of (i) the full term for which he or she shall have been elected or (ii)
the payment of twelve consecutive monthly Dividends.

       (c)   Unless the vote or consent of the holders of a greater number of
shares is then required by law, the affirmative vote or consent of the holders
of at least two-thirds of the aggregate liquidation preference of the Series C
Preferred Stock and of the shares of any Parity Stock at the time outstanding,
given in person or by proxy, either in writing or by a vote at a meeting called
for the purpose at which the holders of Series C Preferred Stock and any such
other series of Parity Stock will vote together as a single class without regard
to series, will be necessary for authorizing, effecting or validating any
variation or abrogation of the powers, preferences, rights, privileges,
qualifications, limitations and restrictions of the Series C Preferred Stock or
any such other series of Parity Stock by way of amendment, alteration or repeal
of any of the provisions of the Charter of the Company, or of any amendment or
supplement thereto, or otherwise (including any certificate of amendment or any
similar document relating to any series of Company preferred stock).
Notwithstanding the foregoing, the Company may, without the consent or sanction
of the holders of Series C Preferred Stock, authorize or issue capital stock of
the Company ranking, as to dividend rights and rights on liquidation, winding up
and dissolution, on a parity with or junior to the Series C Preferred Stock.

       (d)   Unless the vote or consent of the holders of a greater number of
shares shall then be required by law, the affirmative vote or consent of the
holders of at least two-thirds of the aggregate liquidation preference of the
Series C Preferred Stock and any other series of Parity Stock at the time
outstanding, given in person or by proxy, either in writing or by a vote at a
meeting called for the purpose at which the holders of Series C Preferred Stock
and any such other series of Parity Stock shall vote together as a single class
without regard to series, shall be necessary to create, authorize or issue, or
reclassify any authorized capital stock of the Company into, or create,
authorize or issue any obligation or security convertible into or evidencing a
right to purchase, any shares of any class of stock of the Company ranking prior
to both the Series C Preferred Stock and any other series of Parity Stock.
Subject to the foregoing, the Company's Charter may be amended to increase the
number of authorized shares of Preferred Stock without the vote of the holders
of Preferred Stock, including the Series C Preferred Stock. No vote of the
holders of the Series C Preferred Stock and any other series of Parity Stock
will be required for the Company to redeem or purchase and cancel the
<PAGE>   8
Series C Preferred Stock in accordance with the Charter or this Certificate of
Corporate Resolution for the Series C Preferred Stock.

       7.    CONVERSION.  The Series C Preferred Stock will not be convertible
into or exchangeable for any other securities of the Company.

       8.    REPLACEMENT OR LOST CERTIFICATES. If any certificate for a share of
Series C Preferred Stock is mutilated or alleged to have been lost, stolen or
destroyed, a new certificate representing the same share shall be issued to the
holder upon request subject to delivery of the old certificate or, if alleged to
have been lost, stolen or destroyed, subject to compliance with such conditions
as to evidence, indemnity and the payment of out-of-pocket expenses of the
Company in connection with the request, as the Board of Directors of the Company
may determine.

       9.    NO PREEMPTIVE RIGHTS.  Holders of Series C Preferred Stock will
have no preemptive or preferential rights to purchase any securities of the
Company.

<PAGE>   9

       IN WITNESS WHEREOF, the undersigned hereby certify that the above
resolutions were duly adopted by the Board of Directors of the Company on March
29, 2001.

                                      By:  /s/
                                          -------------------------------------
                                      Name:  Frank C. Stipes
                                      Title: President

                                      By:  /s/
                                          -------------------------------------
                                      Name:  Pedro R. Dominguez
                                      Title: Assistant Secretary

       Affidavit No.

       Sworn and subscribed before me by Frank C. Stipes, of legal age,
married, President of W Holding Company, Inc. and a resident of Mayaguez, Puerto
Rico, and Pedro R. Dominguez, of legal age, married, Assistant Secretary of W
Holding Company, Inc. and a resident of Mayaguez, Puerto Rico, to me personally
known.

       In Mayaguez, Puerto Rico, on the 29th day of March, 2001.

                                          /s/
                                          -------------------------------------
                                          Notary Public<PAGE>   1
                                      November 13, 2000

David Wright
1760 Holly Beach Farm Road
Annapolis, MD  21401

Dear David:

        I am pleased to offer you employment with Guilford Pharmaceuticals Inc.
on the following terms:

        1.      Your title will be Executive Vice President, Commercial
                Operations. In this capacity you will serve as an officer of the
                Company and will report to and serve at the discretion of the
                President and Chief Executive Officer.

        2.      In consideration of your services, the Company will provide the
                following compensation:

                a.      Salary: Your salary will be $26,666.66 per month (an
                        annual rate of $320,000), payable semi-monthly. Your
                        performance and salary will be reviewed annually.

                b.      Bonus: As an officer of the Company, you will be
                        eligible to participate in any bonus plan the Board of
                        Directors may adopt from time to time for executive
                        officers of the Company.

                c.      Joining Bonus: To assist you in the transition to your
                        new position, the Company will pay you a joining bonus
                        of $30,000. This payment will be made within 30 days of
                        commencement of your employment, provided you remain an
                        employee of the Company at the time of such payment, and
                        will be subject to all deductions required by law.

                d.      Stock Options: The Company will award you, as of the
                        later of the date this award is approved by the Board of
                        Directors or the date you commence employment with the
                        Company (the "Grant Date"), options to purchase 175,000
                        shares of its common stock, subject to the specific
                        terms and conditions of a Share Option Agreement
                        containing terms similar to those offered to other
                        executive officers of the Company. The exercise price of
                        the options will be the closing price of Guilford's
                        stock on the trading date immediately preceding the
                        Grant Date.

<PAGE>   2

David Wright
November 13, 2000
Page 2

                        Subject to the specific terms of the Share Option
                        Agreement:

                        (i)     vesting of options relating to 25,000 shares
                                shall occur immediately upon the Grant Date;

                        (ii)    vesting of options relating to 100,000 shares
                                shall occur 25% per year over four years from
                                the Grant Date;

                        (ii)    vesting of options relating to 50,000 shares
                                shall occur on March 1 following the first
                                calendar year during which the Company has
                                received at least $40 million in annual net
                                sales from the Company's sale of GLIADEL(R)
                                Wafer.

                        You will additionally be eligible to participate in any
                        stock option plan the Board of Directors may adopt from
                        time to time for executive officers of the Company.

        3.      In addition to the compensation described above, you will be
                eligible for the following benefits:

                a.      Insurance: The Company will offer medical, dental, and
                        vision benefits under the Company's existing plans.
                        Additional coverage for life, disability, officer and
                        other insurance will also be provided, including $3
                        million worth of split dollar life insurance coverage on
                        terms similar to those available to other executive
                        officers of the Company, subject to passage of an
                        eligibility period and commercially reasonable
                        underwriting.

                b.      Vacation: You will accrue up to 20 vacation days during
                        your first year of employment. In addition, you will be
                        eligible for 11 paid Company Holidays.

                c.      401(k) Match: Once you meet the employment eligibility
                        requirements to participate in the company's 401(k)
                        Plan, you will be eligible to receive the Company match
                        subject to the terms and conditions of such plan as may
                        be in effect from time to time. Guilford currently
                        matches 50% of the first 6% of employee salary deferral
                        in the form of Guilford stock.

        In the event your employment is terminated by the Company other than for
cause, you would be entitled to severance in the form of a continuation of your
then-current base salary, as follows:

        1.      Six (6) months salary if the termination occurs in the first
                twelve months of your employment; and

        2.      Twelve (12) months salary if the termination occurs thereafter.

<PAGE>   3

David Wright
November 13, 2000
Page 3

        Such payments (except those resulting from a change in control, see
below) would cease upon your commencement of paid employment or consultancy
during the severance period. During the severance period, the Company would also
reimburse you for the cost of continuation of any health, life and disability
insurance coverage available at the time of the termination of employment,
provided that the Company reserves the right to provide substantially equivalent
alternative life and disability coverage to the extent reasonably available upon
conversion from full-time employment. Such continuing coverage is conditioned
upon your reasonable cooperation in complying with any necessary application
procedures. Remaining benefits of employment, including your eligibility for any
bonus program and the vesting of unvested options would cease at termination and
not continue to accrue during the severance period.

        The Company offers certain terms in the event of a change in control of
the Company, including acceleration of vesting of unvested stock options,
indemnity for certain excise tax obligations and increased and modified
severance arrangements, pursuant to standard agreements generally available to
Vice Presidents of the Company. These terms will be extended to you upon
commencement of your hire.

        In accordance with the Immigration Reform Act of 1986, on your first day
of work, and from time to time thereafter, you will be required to present
documentation that proves your identity and legal right to work in the United
States. Employment with the company is contingent on your being able to meet
this requirement.

        This offer of employment at will is further conditioned on:

                (i)     your signing a Patent and Confidentiality Agreement in
                        connection with your employment by the Company;

                (ii)    successful completion of a background investigation; and

                (iii)   your taking a pre-employment physical, and successfully
                        passing the included drug screen, which can be scheduled
                        at your convenience and our expense (given that your
                        start date is in a few days, this requirement will be a
                        post-commencement condition to your employment - please
                        schedule your physical examination as soon as possible).

        You have agreed to commence your employment at Guilford on November 15,
2000. Please return a copy of this letter signed by you upon or before your
commencement of employment with the Company.

<PAGE>   4

David Wright
November 13, 2000
Page 4

        All of us at Guilford are very enthusiastic about your joining our team.
We believe you will be one of the keys to our success.

                                         Sincerely,

                                         Craig R. Smith, M.D.
                                         President and Chief Executive Officer
                                         Guilford Pharmaceuticals Inc.

I accept this offer and agree to comply with all Guilford Pharmaceuticals Inc.
corporate policies and procedures, which may be in effect from time to time. My
physical has been scheduled for _________________.

Agreed to and accepted:

                        ------------------------------
                        David Wright

                        ------------------------------
                        Date

Enclosures:
Physical scheduling information and Questionnaire
List of Acceptable Documents for I-9
Invesco Form, Please complete, sign and return
Returned Stamped Envelope

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00022-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00022-of-00352.parquet"}]]